Literature DB >> 21468952

Exosome isolation for proteomic analyses and RNA profiling.

Douglas D Taylor1, Wolfgang Zacharias, Cicek Gercel-Taylor.   

Abstract

While the existence of exosomes has been known for over three decades, they have garnered recent interest due to their potential diagnostic and therapeutic relevance. The expression and release of specific tumor-derived proteins into the peripheral circulation has served as the centerpiece of cancer screening and diagnosis. Recently, tissue-associated microRNA (miRNA) has been shown to be characteristic of tumor type and developmental origin, as well as exhibit diagnostic potential. Tumors actively release exosomes, exhibiting proteins and RNAs derived from the originating cell, into the peripheral circulation and other biologic fluids. Recently, we have demonstrated the presence of miRNAs within the RNA fraction of circulating tumor-derived exosomes. Currently, in over 75 investigations compiled in ExoCarta, over 2,300 proteins and 270 miRNAs have been linked with exosomes derived from biologic fluids. Our previous work has indicated that these circulating exosomal proteins and miRNAs can serve as surrogates for the tumor cell-associated counterparts, extending their diagnostic potential to asymptomatic individuals. In this chapter, we compare currently utilized methods for purifying exosomes for postisolation analyses. The exosomes derived from these approaches were assessed for quantity and quality of specific RNA populations and specific marker proteins. These results suggest that, while each method purifies exosomal material, circulating exosomes isolated by ExoQuick precipitation produces exosomal RNA and protein with greater purity and quantity than chromatography, ultracentrifugation, and DynaBeads. While this precipitation approach isolates exosomes in general and does not exhibit specificity for the originating cell, the increased quantity and quality of exosomal proteins and RNA should enhance the sensitivity and accuracy of down-stream analyses, such as qRT-PCR profiling of miRNA and mass spectrometric and electrophoretic analyses of exosomal proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468952     DOI: 10.1007/978-1-61779-068-3_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  149 in total

1.  Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.

Authors:  Prachi P Singh; Victoria L Smith; Petros C Karakousis; Jeffery S Schorey
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

Review 2.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

3.  Identification and analysis of exosomes secreted from macrophages extracted by different methods.

Authors:  Jianjun Wang; Yongliang Yao; Jianhong Wu; Guangxin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 4.  Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: Current status and future directions.

Authors:  Shima Gholizadeh; Mohamed Shehata Draz; Maryam Zarghooni; Amir Sanati-Nezhad; Saeid Ghavami; Hadi Shafiee; Mohsen Akbari
Journal:  Biosens Bioelectron       Date:  2016-12-30       Impact factor: 10.618

5.  Isolation and Analysis of Tumor-Derived Exosomes.

Authors:  Nils Ludwig; Chang-Sook Hong; Sonja Ludwig; Juliana H Azambuja; Priyanka Sharma; Marie-Nicole Theodoraki; Theresa L Whiteside
Journal:  Curr Protoc Immunol       Date:  2019-12

6.  Increasing vaccine potency through exosome antigen targeting.

Authors:  Zachary C Hartman; Junping Wei; Oliver K Glass; Hongtao Guo; Gangjun Lei; Xiao-Yi Yang; Takuya Osada; Amy Hobeika; Alain Delcayre; Jean-Bernard Le Pecq; Michael A Morse; Timothy M Clay; Herbert K Lyerly
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

7.  Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).

Authors:  Guanghu Wang; Michael Dinkins; Qian He; Gu Zhu; Christophe Poirier; Andrew Campbell; Margot Mayer-Proschel; Erhard Bieberich
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

8.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

9.  A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.

Authors:  Lorea Manterola; Elizabeth Guruceaga; Jaime Gállego Pérez-Larraya; Marisol González-Huarriz; Patricia Jauregui; Sonia Tejada; Ricardo Diez-Valle; Victor Segura; Nicolás Samprón; Cristina Barrena; Irune Ruiz; Amaia Agirre; Angel Ayuso; Javier Rodríguez; Alvaro González; Enric Xipell; Ander Matheu; Adolfo López de Munain; Teresa Tuñón; Idoya Zazpe; Jesús García-Foncillas; Sophie Paris; Jean Yves Delattre; Marta M Alonso
Journal:  Neuro Oncol       Date:  2014-01-16       Impact factor: 12.300

10.  Antigenic composition of single nano-sized extracellular blood vesicles.

Authors:  Anush Arakelyan; Oxana Ivanova; Elena Vasilieva; Jean-Charles Grivel; Leonid Margolis
Journal:  Nanomedicine       Date:  2014-12-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.